KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Receivables - Other: 2023-2025

Historic Receivables - Other for Exact Sciences (EXAS) over the last 2 years, with Sep 2025 value amounting to $31.8 million.

  • Exact Sciences' Receivables - Other fell 34.16% to $31.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.8 million, marking a year-over-year decrease of 34.16%. This contributed to the annual value of $25.9 million for FY2024, which is 37.89% down from last year.
  • Exact Sciences' Receivables - Other amounted to $31.8 million in Q3 2025, which was down 2.75% from $32.7 million recorded in Q2 2025.
  • In the past 5 years, Exact Sciences' Receivables - Other ranged from a high of $68.9 million in Q3 2023 and a low of $25.9 million during Q4 2024.
  • Its 3-year average for Receivables - Other is $40.6 million, with a median of $41.4 million in 2024.
  • Data for Exact Sciences' Receivables - Other shows a maximum YoY crashed of 37.89% (in 2024) over the last 5 years.
  • Exact Sciences' Receivables - Other (Quarterly) stood at $41.7 million in 2023, then crashed by 37.89% to $25.9 million in 2024, then crashed by 34.16% to $31.8 million in 2025.
  • Its Receivables - Other was $31.8 million in Q3 2025, compared to $32.7 million in Q2 2025 and $29.9 million in Q1 2025.